Outcome predictors in patients with idiopathic inflammatory myopathies

Clinical and Experimental Rheumatology

Volumn 30, Issue 6, 2012, Pages 980-

  Salvador, F B ^a   Isenberg, D A ^b  

^a Centro Hospitalar de Tras os Montes e Alto Douro   (Portugal)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE ANTIBODY; AUTOANTIBODY; CADM 140 ANTIBODY; CREATINE KINASE; JO 1 ANTIBODY; SIGNAL RECOGNITION PARTICLE ANTIBODY; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANTIBODY DETECTION; CREATINE KINASE BLOOD LEVEL; DELAYED DIAGNOSIS; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; HISTOLOGY; HUMAN; IMMUNOPRECIPITATION; INCLUSION BODY MYOSITIS; LETTER; MYOSITIS; NEOPLASM; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SURVIVAL RATE;

AGE FACTORS; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; DELAYED DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REMISSION INDUCTION; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84872714933     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. MARIE I, HATRON PY, LEVESQUE H et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 1999; 78: 139-47.
2. AIRIO A, KAUTIAINEN H, HAKALA M: Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 2006; 25: 234-9.
3. DANKO K, PONYI A, CONSTANTIN T, BORGULYA G, SZEGEDI G: Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 2004; 83: 35-42.
4. MARIE I, HACHULLA E, HATRON PY et al. Polymyositis and dermatomyositis: short term and long term outcome and predictive factors of prognosis. J Rheumatol 2001; 28: 2230-7.
5. BRONNER IM, MEULEN M, VISSER M et al. Longterm outcome in polymyositis and dermatomyositis. Ann Rheum Dis 2006; 65: 1456-61.
6. ANDRÁS C, PONYI A, CONSTANTIN T et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 2008; 35: 438-44.
7. FUDMAN EJ, SCHNITZER TJ: Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 1986; 80: 329-32.
8. HENGSTMAN G, EGBERTS W, SEELIG H et al. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen. Ann Rheum Dis 2006; 65: 242-5.
9. KAO AH, LACOMIS D, LUCAS M, FERTIG N, ODDIS CV: Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004; 50: 209-15.
10. KAJI K, FUJIMOTO M, HASEGAWA M et al. Identification of a novel autoantibody reactive with 155 and 140Kd nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology 2007; 46: 25-8.